The Source of New HIV Infections are People not being Treated or Unaware of their Status
Autor:
Soriano, Vicente (1)
Fecha:
04/2019Palabra clave:
Tipo de Ítem:
Articulo Revista Indexada
Resumen:
The advent of antiretroviral therapy has represented a major breakthrough in infectious diseases. The use of HAART prevents HIV disease progression and restores immunity in HIV carriers. In addition, further transmissions are halted (treatment as prevention [TAP]). More recently, the use of antiretrovirals by uninfected individuals at risk (pre-exposure prophylaxis [PrEP]) has shown to drastically reduce the chances of HIV acquisition. Despite all these tremendous advances, the figures for the HIV pandemic remain dreadful, with estimates of 38 million people living with HIV worldwide and 1.8 million new infections occurring each year. Looking at this scenario, the call from the UNAIDS toward a 95-95-95 goal for 2030 seems unachievable, unless new strategies are set up.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
38 |
19 |
8 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Hepatitis delta in patients with resolved hepatitis B virus infection
Aguilera, Antonio; Rodríguez-Calviño, Javier; Mendoza, Carmen de; Soriano, Vicente (1) (European Journal of Gastroenterology & Hepatology, 09/2018)Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals ... -
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
Aguilera, Antonio; Trastoy, Rocío; Rodríguez-Calviño, Javier; Manso, Tamara; Mendoza, Carmen de; Soriano, Vicente (1) (European Journal of Gastroenterology & Hepatology, 09/2018)Background Hepatitis delta virus (HDV) is a defective agent that only replicates in the presence of the hepatitis B virus. Accordingly, HDV acquisition may occur as superinfection of HBsAg+ carriers or following acute dual ... -
Hepatitis B Gene Therapy Coming to Age
Soriano, Vicente (1) (AIDS Reviews, 04/2018)The major pandemics caused by chronic viral infections is produced by HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV), with estimates of 38, 70, and 250 million people worldwide, respectively (Fig. 1). During the ...